Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
Cytek BioSciences Inc (NASDAQ: CTKB) closed the day trading at $2.67 down -0.37% from the previous closing price of $2.68. In other words, the price has decreased by -$0.37 from its previous closing price. On the day, 1.44 million shares were traded.
Ratios:
For a better understanding of CTKB, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.27 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 19.34. For the most recent quarter (mrq), Quick Ratio is recorded 4.95 and its Current Ratio is at 5.62. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.05.
On January 31, 2025, Goldman Downgraded its rating to Sell which previously was Buy and also lowered its target price recommendation from $7 to $4.50.
On December 14, 2023, Stephens started tracking the stock assigning a Overweight rating and target price of $9.Stephens initiated its Overweight rating on December 14, 2023, with a $9 target price.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 1.72 while its Price-to-Book (P/B) ratio in mrq is 0.90.
Stock Price History:
Over the past 52 weeks, CTKB has reached a high of $7.63, while it has fallen to a 52-week low of $2.60. The 50-Day Moving Average of the stock is -29.42%, while the 200-Day Moving Average is calculated to be -48.84%.
Shares Statistics:
A total of 127.60M shares are outstanding, with a floating share count of 114.78M. Insiders hold about 9.38% of the company’s shares, while institutions hold 60.90% stake in the company.
